Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323603 | SCV001514526 | likely benign | Nemaline myopathy 2 | 2023-10-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001323603 | SCV002077058 | uncertain significance | Nemaline myopathy 2 | 2020-02-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004548165 | SCV004773482 | uncertain significance | NEB-related disorder | 2023-11-22 | no assertion criteria provided | clinical testing | The NEB c.11982C>G variant is predicted to result in the amino acid substitution p.Ile3994Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |